Ziopharm Oncology Treatment for T-cell Lymphoma Receives Orphan Drug Designation

Ziopharm Oncology Treatment for T-cell Lymphoma Receives Orphan Drug Designation
Ziopharm Oncology said the US Food and Drug Administration has provided its treatment for T-cell Lymphoma with Orphan Drug Designation.

Read more on FOX Business